Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
Sponsor: Bristol-Myers Squibb
Summary
The purpose of this study is to assess BMS-986500 as monotherapy in advanced solid tumors and as combination therapy in CDK4/6 inhibitor pre-treated advanced breast cancer.
Official title: A Phase 1 First-in-human Study of BMS-986500 as Monotherapy in Advanced Solid Tumors and as Combination Therapy in CDK4/6 Inhibitor Pre-treated Advanced Breast Cancer
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
234
Start Date
2025-08-01
Completion Date
2028-12-14
Last Updated
2026-04-07
Healthy Volunteers
No
Interventions
BMS-986500
Specified dose of specified days
Palbociclib
Specified dose on specified days
Fulvestrant
Specified dose on specified days
Locations (21)
University of Alabama at Birmingham
Birmingham, Alabama, United States
Providence St. Jude Medical Center
Fullerton, California, United States
Marin Cancer Care
Greenbrae, California, United States
Moores Cancer Center
La Jolla, California, United States
Hoag Memorial Hospital Presbyterian
Newport Beach, California, United States
Local Institution - 0008
Aurora, Colorado, United States
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Washington University School of Medicine
St Louis, Missouri, United States
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States
Local Institution - 0014
Buffalo, New York, United States
Northwell Health-Cancer Institute
New Hyde Park, New York, United States
Local Institution - 0011
New York, New York, United States
Memorial Sloan Kettering Cancer Center
New York, New York, United States
START Dallas Fort Worth
Fort Worth, Texas, United States
NEXT Oncology
San Antonio, Texas, United States
Odense Universitetshospital
Odense, Region Syddanmark, Denmark
Local Institution - 0025
Copenhagen, Denmark
National Cancer Center Hospital East
Kashiwa, Chiba, Japan
Kansai Medical University Hospital
Hirakata, Osaka, Japan
National Cancer Center Hospital
Chuo-ku, Tokyo, Japan
The Cancer Institute Hospital of JFCR
Koto-ku, Tokyo, Japan